Mativ Holdings, Inc. (MATV) - Q3 2025 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 2025. Mativ Holdings, Inc. operates as a global leader in specialty materials with two reportable segments: Filtration & Advanced Materials (FAM) and Sustainable & Adhesive Solutions (SAS). The Engineered Papers business was divested in November 2023 and is reported as a discontinued operation.
Key Financial Metrics
| Metric (in millions) | Q3 2025 | Q3 2024 | 9M 2025 | 9M 2024 |
|---|---|---|---|---|
| Net Sales | $513.7 | $498.5 | $1,523.9 | $1,522.5 |
| Gross Profit | $99.4 | $93.6 | $275.7 | $286.5 |
| Gross Margin | 19.3% | 18.8% | 18.1% | 18.8% |
| Operating Profit (Loss) | $16.0 | $7.0 | $(394.5) | $3.7 |
| Net Loss | $(3.2) | $(20.8) | $(438.2) | $(50.2) |
| Diluted EPS | $(0.06) | $(0.38) | $(8.04) | $(0.93) |
| Cash from Operations (9M) | $114.5 (vs $70.7 prior year) | |||
| Total Debt | $1,028.9 (Sep 30, 2025) | |||
| Cash & Equivalents | $97.1 (Sep 30, 2025) |
Material Changes vs. Prior Period
- Goodwill Impairment: The nine-month 2025 results were significantly impacted by a $411.9 million non-cash goodwill impairment charge recorded in the first quarter. This charge was attributed entirely to the FAM segment following an interim quantitative impairment test triggered by a sustained decline in the Company's share price.
- Segment Performance:
- FAM: Q3 operating profit was $11.4 million, down 42.7% year-over-year due to higher restructuring/impairment costs and manufacturing expenses, despite a 4.6% sales increase.
- SAS: Q3 operating profit surged to $28.4 million (up from $10.3 million) driven by lower restructuring costs, favorable pricing vs. input costs, and reduced SG&A expenses.
- Restructuring: Total restructuring and other impairment expenses were $8.1 million in Q3 2025, down from $11.2 million in Q3 2024. This included a $6.0 million impairment charge in the FAM segment for long-lived assets at a North American facility scheduled for closure in Q4 2025.
- Liquidity: Net leverage ratio stood at 4.2x at quarter-end, well below the 5.50x covenant maximum. Undrawn capacity on the revolving credit facility was $420.2 million.
Guidance, Outlook, and Risks
- Tariff Uncertainty: Management highlighted significant uncertainty regarding U.S. tariff regimes and potential retaliatory tariffs, which could impact macroeconomic conditions and costs.
- Future Impairment Risk: While the SAS segment passed its impairment test with a fair value exceeding carrying value by approximately 6%, management noted that a 100bps increase in the discount rate could result in an impairment of approximately $15.0 million. Further declines in share price or adverse economic conditions could trigger future charges.
- Pension Activities: The Company executed a buy-in of UK pension plan assets and purchased an annuity contract for the U.S. plan, resulting in a $3.6 million non-cash settlement loss in Q3.
- Dividends: A cash dividend of $0.10 per share was declared on November 5, 2025, payable December 19, 2025.
- Share Repurchases: No shares were repurchased in Q3 2025. As of November 3, 2025, $22.0 million remained under the $30.0 million authorization.
Investor Verification Checklist
- Goodwill Impairment Drivers: Verify the specific assumptions used in the FAM impairment test, particularly the 14% discount rate and the impact of the share price decline.
- SAS Segment Sensitivity: Monitor the SAS segment's fair value relative to its carrying value, given the narrow margin of safety (6%) and sensitivity to discount rate changes.
- Tariff Impact: Assess the Company's exposure to new U.S. tariffs and potential supply chain cost increases in the coming quarters.
- Debt Covenants: Confirm continued compliance with the 5.50x net debt-to-EBITDA covenant, especially given the recent goodwill charge and potential future restructuring costs.
- Facility Closure Costs: Track the execution of the North American facility closure in Q4 2025 and associated costs (estimated not to exceed $0.5 million).